Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2650
+0.0200 (8.16%)
Oct 14, 2025, 12:07 PM EDT
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $20.48 million as of October 14, 2025. Its market cap has increased by 304.46% in one year.
Market Cap
20.48M
Enterprise Value
24.74M
Revenue
118.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since July 1, 1997, Guided Therapeutics's market cap has decreased from 448.72M to 20.48M, a decrease of -95.44%. That is a compound annual growth rate of -10.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 20.48M | 109.65% |
| Dec 31, 2024 | 9.77M | 17.63% |
| Dec 29, 2023 | 8.31M | -43.03% |
| Dec 30, 2022 | 14.58M | 84.30% |
| Dec 31, 2021 | 7.91M | 101.40% |
| Dec 31, 2020 | 3.93M | 789.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |